Results 41 to 50 of about 1,591,431 (356)
Clinical Microbiology and Infection, 2021 Background Vaccines are critical cost-effective tools to control the coronavirus disease 2019 (COVID-19) pandemic. However, the emergence of variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may threaten the global impact of ...
Thibault Fiolet +4 more
semanticscholar +1 more source
Acknowledgement to Reviewers of Vaccines in 2013
Vaccines, 2014 The editors of Vaccines would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2013.
Vaccines Editorial Office
doaj +1 more source
Development of an experimental inactivated PRRSV vaccine that induces virus-neutralizing antibodies [PDF]
, 2009 Porcine reproductive and respiratory syndrome virus (PRRSV) can induce reproductive disorders and is involved in the porcine respiratory disease complex, causing tremendous economic losses to the swine industry.
Delputte, Peter +4 more
core +3 more sources
Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines
Vaccines, 2023 Lipid nanoparticles (LNPs) have recently emerged as one of the most advanced technologies for the highly efficient in vivo delivery of exogenous mRNA, particularly for COVID-19 vaccine delivery.
K. Swetha +7 more
semanticscholar +1 more source
Acknowledgement to Reviewers of Vaccines in 2017
Vaccines, 2018 Peer review is an essential part in the publication process, ensuring that Vaccines maintains high quality standards for its published papers.[...]
Vaccines Editorial Office
doaj +1 more source
BMC Medical Research Methodology, 2021 Background Randomized controlled trials are considered the gold standard to evaluate causal associations, whereas assessing causality in observational studies is challenging.
Emilia Gvozdenović +6 more
doaj +1 more source
Mucosal vaccines — fortifying the frontiers
Nature reviews. Immunology, 2021 Mucosal vaccines offer the potential to trigger robust protective immune responses at the predominant sites of pathogen infection. In principle, the induction of adaptive immunity at mucosal sites, involving secretory antibody responses and tissue ...
E. Lavelle, Ross W. Ward
semanticscholar +1 more source
Viral targets for vaccines against COVID-19
Nature reviews. Immunology, 2020 Vaccines are urgently needed to control the coronavirus disease 2019 (COVID-19) pandemic and to help the return to pre-pandemic normalcy. A great many vaccine candidates are being developed, several of which have completed late-stage clinical trials and ...
L. Dai, G. Gao
semanticscholar +1 more source
Conjugate Haemophilus influenzae type b vaccines for sickle cell disease. [PDF]
, 2016 BACKGROUND: People affected with sickle cell disease are at high risk of infection from Haemophilus influenzae type b. Before the implementation of Haemophilus influenzae type b conjugate vaccination in high-income countries, this was responsible for a ...
Allali, Slimane +4 more
core +2 more sources
Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review
Vaccines, 2020 While COVID-19 continues raging worldwide, effective vaccines are highly anticipated. However, vaccine hesitancy is widespread. Survey results on uptake intentions vary and continue to change.
Cheryl Lin, Pikuei Tu, L. Beitsch
semanticscholar +1 more source